[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.163.159.27. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Letters
April 28, 2004

Ranolazine as Add-on Therapy for Patients With Severe Chronic Angina—Reply

Author Affiliations
 

Letters Section Editor: Stephen J. Lurie, MD, PhD, Senior Editor.

JAMA. 2004;291(16):1959. doi:10.1001/jama.291.16.1959-c

In Reply: In response to Drs Hooper and Busti, the improvements in exercise performance due to ranolazine in our study, as well as the magnitude of the placebo effect, are similar to those reported in studies of other widely prescribed antianginal drugs.1 In an earlier cross-over study of immediate-release ranolazine 400 mg twice daily vs atenolol 100 mg/d vs placebo, ranolazine at plasma concentrations similar to those in our study produced increases in exercise performance that were as large or larger than those effected by atenolol.2

First Page Preview View Large
First page PDF preview
First page PDF preview
×